Lunate Capital LTD Portfolio Holdings

Lunate Capital LTD

  • $264 Billion
  • Q4 2025

Lunate Capital LTD has filed its 13F form on January 23, 2026 for Q4 2025 where it was disclosed a total value porftolio of $264 Billion distributed in 6 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Revolution Medicines, Inc. with a value of $175B, Sailpoint Inc with a value of $60.7B, Lineage Inc with a value of $21B, Neumora Therapeutics Inc. with a value of $3.8B, and Navan Inc with a value of $3.42B.

Examining the 13F form we can see an increase of $43.5B in the current position value, from $221B to 264B.

Lunate Capital LTD is based out at Al Maryah Island, Abu Dhabi, C0

Below you can find more details about Lunate Capital LTD portfolio as well as his latest detailed transactions.

Portfolio value $264 Billion
Healthcare: $175 Billion

Stock Holdings Table Market Cap. of $2 Billions to $10 Billions

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$5.94B
$175 Billion 66.2% of portfolio
2,196,200
Q1 2025 New

Summary

  • Portfolio
  • No. of Stocks 6
  • Current Value $264 Billion
  • Prior Value $221 Billion
  • Filing
  • Period Q4 2025
  • Filing Date January 23, 2026
  • Form Type 13F-HR
  • Activity in Q4 2025
  • New Purchases 1 stocks
  • Additional Purchases 0 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 0 stocks
Track This Portfolio

Track Lunate Capital LTD Portfolio

Follow Lunate Capital LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lunate Capital LTD, based on Form 13F filings with the SEC.

News

Stay updated on Lunate Capital LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email